Abbott Laboratories Reaffirms FY26 Adj. EPS Outlook - Update
(RTTNews) - While reporting financial results for the third quarter on Wednesday, healthcare company Abbott Laboratories (ABT) provided adjusted earnings guidance for the fourth quarter and reaffirmed its adjusted earnings outlook for the full-year 2026.